Gemina Laboratories Stock Market Value
| GLABF Stock | USD 0.77 0.03 4.05% |
| Symbol | Gemina |
Gemina Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gemina Laboratories' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gemina Laboratories.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Gemina Laboratories on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Gemina Laboratories or generate 0.0% return on investment in Gemina Laboratories over 90 days. Gemina Laboratories is related to or competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, and PTC Therapeutics. Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vit... More
Gemina Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gemina Laboratories' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gemina Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.54 | |||
| Information Ratio | 0.1254 | |||
| Maximum Drawdown | 51.6 | |||
| Value At Risk | (8.16) | |||
| Potential Upside | 11.11 |
Gemina Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gemina Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gemina Laboratories' standard deviation. In reality, there are many statistical measures that can use Gemina Laboratories historical prices to predict the future Gemina Laboratories' volatility.| Risk Adjusted Performance | 0.1049 | |||
| Jensen Alpha | 0.6636 | |||
| Total Risk Alpha | 1.55 | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | (1.37) |
Gemina Laboratories Backtested Returns
Gemina Laboratories is out of control given 3 months investment horizon. Gemina Laboratories holds Efficiency (Sharpe) Ratio of 0.17, which attests that the entity had a 0.17 % return per unit of risk over the last 3 months. We have analyzed twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.1% are justified by taking the suggested risk. Use Gemina Laboratories Market Risk Adjusted Performance of (1.36), risk adjusted performance of 0.1049, and Downside Deviation of 15.54 to evaluate company specific risk that cannot be diversified away. Gemina Laboratories holds a performance score of 13 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.52, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Gemina Laboratories are expected to decrease at a much lower rate. During the bear market, Gemina Laboratories is likely to outperform the market. Use Gemina Laboratories maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to analyze future returns on Gemina Laboratories.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Gemina Laboratories has insignificant reverse predictability. Overlapping area represents the amount of predictability between Gemina Laboratories time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gemina Laboratories price movement. The serial correlation of -0.18 indicates that over 18.0% of current Gemina Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Gemina Laboratories lagged returns against current returns
Autocorrelation, which is Gemina Laboratories otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gemina Laboratories' otc stock expected returns. We can calculate the autocorrelation of Gemina Laboratories returns to help us make a trade decision. For example, suppose you find that Gemina Laboratories has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gemina Laboratories regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gemina Laboratories otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gemina Laboratories otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gemina Laboratories otc stock over time.
Current vs Lagged Prices |
| Timeline |
Gemina Laboratories Lagged Returns
When evaluating Gemina Laboratories' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gemina Laboratories otc stock have on its future price. Gemina Laboratories autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gemina Laboratories autocorrelation shows the relationship between Gemina Laboratories otc stock current value and its past values and can show if there is a momentum factor associated with investing in Gemina Laboratories.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Gemina OTC Stock
Gemina Laboratories financial ratios help investors to determine whether Gemina OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.